Neutralizing antibodies against SARS-CoV-2 virus after vaccination in patients with neurofibromatosis type 1.
Qiao-Ling RuanZhi-Chao WangCheng-Jiang WeiWei WangQing-Luan YangJing WuYan-Min WanLing-Ling GeWen-Hong ZhangQing-Feng LiPublished in: Signal transduction and targeted therapy (2023)